Suchergebnisse - "Hernández-Sánchez, Jesús María"

PubPharm (20)

1

Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes

enthalten in: Therapeutic advances in hematology | 2024

von Caballero, J. | Dávila, J. | López-Pavía, M. | +17

2

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia

enthalten in: Clinical and translational medicine | 2021

von Quijada-Álamo, M. | Pérez-Carretero, C. | Hernández-Sánchez, M. | +16

3

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia

enthalten in: Clinical and Translational Medicine | 2021

von Quijada‐Álamo, M. | Pérez‐Carretero, C. | Hernández‐Sánchez, M. | +16

4

Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag

enthalten in: Platelets | 2020

von Hernández-Sánchez, J. | Bastida, J. | Alonso-López, D. | +5

5

Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications

enthalten in: International journal of cancer | 2020

von Pérez-Carretero, C. | Hernández-Sánchez, M. | González, T. | +17

6

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

enthalten in: Leukemia | 2020

von Quijada-Álamo, M. | Hernández-Sánchez, M. | Alonso-Pérez, V. | +15

7

Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide

enthalten in: British journal of haematology | 2020

von Adema, V. | Palomo, L. | Toma, A. | +17

8

The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma : Ready for prime time?

enthalten in: Cancer genetics | 2020

von Höllein, A. | Twardziok, S. | Walter, W. | +7

9

Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency

enthalten in: bioRxiv.org | 2020

von García-Tuñón, I. | Alonso-Pérez, V. | Vuelta, E. | +10

10

Distinct mutational pattern of myelodysplastic syndromes with and without 5q– treated with lenalidomide

enthalten in: British Journal of Haematology | 2020

von Adema, V. | Palomo, L. | Toma, A. | +17